301
Views
2
CrossRef citations to date
0
Altmetric
Commentary

High-dose thiotepa-based conditioning regimens for relapsed lymphoma involving the central nervous system: from “orphan drug” to a standard-of-care?

&
Pages 1-3 | Received 15 May 2015, Accepted 15 May 2015, Published online: 07 Jul 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.